These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

216 related articles for article (PubMed ID: 20501750)

  • 1. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.
    Ashley DL; O'Connor RJ; Bernert JT; Watson CH; Polzin GM; Jain RB; Hammond D; Hatsukami DK; Giovino GA; Cummings KM; McNeill A; Shahab L; King B; Fong GT; Zhang L; Xia Y; Yan X; McCraw JM
    Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1389-98. PubMed ID: 20501750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
    Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
    Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: A population-based study.
    Pérez-Ortuño R; Martínez-Sánchez JM; Fu M; Ballbè M; Quirós N; Fernández E; Pascual JA
    Environ Res; 2016 Nov; 151():635-641. PubMed ID: 27619208
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TSNA Exposure: Levels of NNAL Among Canadian Tobacco Users.
    Czoli CD; Hammond D
    Nicotine Tob Res; 2015 Jul; 17(7):825-30. PubMed ID: 25481919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolism of nicotine and 4-(methylnitrosamino)-l-(3-pyridyl)-lbutanone (NNK) in menthol and non-menthol cigarette smokers.
    Sarkar M; Wang J; Liang Q
    Drug Metab Lett; 2012 Sep; 6(3):198-206. PubMed ID: 23140558
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Analysis of human urine for pyridine-N-oxide metabolites of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone, a tobacco-specific lung carcinogen.
    Carmella SG; Borukhova A; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Feb; 6(2):113-20. PubMed ID: 9037562
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Investigation of exposure biomarkers in human plasma following differing levels of tobacco-specific N-nitrosamines and nicotine in cigarette smoke.
    Zhang J; Liu X; Shi B; Yang Z; Luo Y; Xu T; Liu D; Jiang C; Du G; Lu N; Zhang C; Ma Y; Bai R; Zhou J
    Environ Res; 2022 Nov; 214(Pt 2):113811. PubMed ID: 35835167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study to estimate and correlate cigarette smoke exposure in smokers in Germany as determined by filter analysis and biomarkers of exposure.
    Shepperd CJ; Eldridge AC; Mariner DC; McEwan M; Errington G; Dixon M
    Regul Toxicol Pharmacol; 2009 Oct; 55(1):97-109. PubMed ID: 19539004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Racial differences in exposure and glucuronidation of the tobacco-specific carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK).
    Muscat JE; Djordjevic MV; Colosimo S; Stellman SD; Richie JP
    Cancer; 2005 Apr; 103(7):1420-6. PubMed ID: 15726545
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Determination of tobacco-specific N-nitrosamines in urine of smokers and non-smokers.
    Kavvadias D; Scherer G; Cheung F; Errington G; Shepperd J; McEwan M
    Biomarkers; 2009 Dec; 14(8):547-53. PubMed ID: 19747086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Urine cotinine underestimates exposure to the tobacco-derived lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in passive compared with active smokers.
    Benowitz N; Goniewicz ML; Eisner MD; Lazcano-Ponce E; Zielinska-Danch W; Koszowski B; Sobczak A; Havel C; Jacob P
    Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2795-800. PubMed ID: 20805316
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Direct analysis of tobacco-specific nitrosamine NNK and its metabolite NNAL in human urine by LC-MS/MS: evidence of linkage to methylated DNA lesions.
    Hu CW; Hsu YW; Chen JL; Tam LM; Chao MR
    Arch Toxicol; 2014 Feb; 88(2):291-9. PubMed ID: 24057573
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A study to evaluate the effect on Mouth Level Exposure and biomarkers of exposure estimates of cigarette smoke exposure following a forced switch to a lower ISO tar yield cigarette.
    Shepperd CJ; Eldridge AC; Errington G; Dixon M
    Regul Toxicol Pharmacol; 2011 Dec; 61(3 Suppl):S13-24. PubMed ID: 21672597
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Development of a method for the determination of 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in urine of nonsmokers and smokers using liquid chromatography/tandem mass spectrometry.
    Hou H; Zhang X; Tian Y; Tang G; Liu Y; Hu Q
    J Pharm Biomed Anal; 2012 Apr; 63():17-22. PubMed ID: 22366322
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Carcinogen Exposure among Canadian Tobacco Users: Changes in NNK Exposure from 2007-2009 through 2012-2013.
    Czoli CD; Hammond D
    Cancer Epidemiol Biomarkers Prev; 2018 Mar; 27(3):262-267. PubMed ID: 29358222
    [No Abstract]   [Full Text] [Related]  

  • 16. Assessing exposure to tobacco-specific carcinogen NNK using its urinary metabolite NNAL measured in US population: 2011-2012.
    Wei B; Blount BC; Xia B; Wang L
    J Expo Sci Environ Epidemiol; 2016; 26(3):249-56. PubMed ID: 25564369
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Differences in the urinary metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone in black and white smokers.
    Richie JP; Carmella SG; Muscat JE; Scott DG; Akerkar SA; Hecht SS
    Cancer Epidemiol Biomarkers Prev; 1997 Oct; 6(10):783-90. PubMed ID: 9332760
    [TBL] [Abstract][Full Text] [Related]  

  • 18. NNAL exposure by race and menthol cigarette use among U.S. smokers.
    Rostron B
    Nicotine Tob Res; 2013 May; 15(5):950-6. PubMed ID: 23089487
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined analysis of the tobacco metabolites cotinine and 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine.
    Kotandeniya D; Carmella SG; Ming X; Murphy SE; Hecht SS
    Anal Chem; 2015 Feb; 87(3):1514-7. PubMed ID: 25544129
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of tobacco-derived compounds in human pancreatic juice.
    Prokopczyk B; Hoffmann D; Bologna M; Cunningham AJ; Trushin N; Akerkar S; Boyiri T; Amin S; Desai D; Colosimo S; Pittman B; Leder G; Ramadani M; Henne-Bruns D; Beger HG; El-Bayoumy K
    Chem Res Toxicol; 2002 May; 15(5):677-85. PubMed ID: 12018989
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.